Atherectomy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Directional, Rotational, Laser, Orbital), By Application (Peripheral, Cardiovascular, Neurovascular), By End User (Hospitals & Surgical Centres, Ambulatory Care Centres, Others), By Region and Competition, 2019-2029F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationAtherectomy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Directional, Rotational, Laser, Orbital), By Application (Peripheral, Cardiovascular, Neurovascular), By End User (Hospitals & Surgical Centres, Ambulatory Care Centres, Others), By Region and Competition, 2019-2029F
| Forecast Period | 2025-2029 |
| Market Size (2023) | USD 890.45 Million |
| Market Size (2029) | USD 1011.21 Million |
| CAGR (2024-2029) | 6.08% |
| Fastest Growing Segment | Directional |
| Largest Market | North America |
Market Overview
Global Atherectomy Devices Market was valued at USD 890.45 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.08% through 2029. Global atherectomy devices market is expected to grow at a significant rate for the forecast period. Growth in the target patient population and developing healthcare infrastructure are the two significant contributing factors leading to surge in the market growth for the next five years. The global atherectomy devices market is witnessing significant growth owing to the increasing prevalence of cardiovascular diseases and technological advancements in atherectomy devices. The market is expected to continue to grow during the forecast period, with the rotational atherectomy devices segment accounting for the largest share of the market. The key players in the market are focusing on product innovation and strategic collaborations to strengthen their market positions and expand their product portfolios. These factors are expected to propel the growth of Global Atherectomy Devices Market.
Key Market Drivers
Growing Prevalence of Cardiovascular Disorders
According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths each year.
New Product Launch and Healthcare Development
For instance, in March 2020, a company namely Straub Medical LLC has launched an atherectomy device called ‘Rotarex S’ used in the treatment of occlusive peripheral vascular disease
For example, in 2019, Avinger, Inc., a medical device company, announced the launch of its next-generation Pantheris SV atherectomy system. This system is designed to provide physicians with better visibility and control during procedures, resulting in improved clinical outcomes for patients.
Another key development in the market is the increasing adoption of laser atherectomy devices. Laser atherectomy devices use laser energy to vaporize plaque in the arteries, and they are becoming increasingly popular due to their precision and effectiveness. In 2021, Cardiovascular Systems, Inc. (CSI), a medical device company, announced the launch of its Diamondback 360® Coronary Orbital Atherectomy System (OAS) with Stealth 360® Technology, which uses a diamond-coated crown to remove plaque and a laser to vaporize any remaining plaque. This in turn, expected to drive the growth of the market. The atherectomy devices market is also seeing increased investment and partnership activities.
Surge in the Usage of Atherectomy Devices
According to National Centre for Biotechnology Information, National Institute of Health, globally the prevalence for coronary artery disease (CAD) is around 5–8% and the prevalence for peripheral artery disease (PAD) is around 10–20%
Technological Advancements & Rising Demand for Minimally Invasive Procedures
Technological advancements in atherectomy devices are also driving the growth of the global market. Manufacturers are increasingly investing in research and development to develop more effective and efficient atherectomy devices. For instance, several new devices have been launched in recent years that use laser technology to remove plaque from arteries. These devices offer several advantages over traditional atherectomy devices, such as reduced risk of complications and faster recovery times. The demand for minimally invasive procedures is on the rise, owing to factors such as faster recovery times, reduced risk of complications, and lower healthcare costs. Atherectomy is a minimally invasive procedure, which is driving the demand for atherectomy devices. These devices offer several advantages over traditional surgical procedures, such as reduced pain and scarring. As these trends continue, the global atherectomy devices market is expected to continue to grow in the forecast years.
Key Market Challenges
Technological Complexity and Cost
One of the significant challenges facing the Global Atherectomy Devices Market is the technological complexity and associated costs. Atherectomy devices utilize advanced technologies such as laser, rotational, orbital, or directional atherectomy to remove plaque buildup from arteries. However, the development and integration of these sophisticated technologies into medical devices require substantial investment in research, development, and manufacturing. Consequently, the high cost of atherectomy devices poses a challenge for healthcare facilities, particularly in regions with limited financial resources or reimbursement constraints.
Adoption Barriers and Training
Key Market Trends
Shift towards Minimally Invasive Procedures
There is a growing trend towards minimally invasive interventions for the treatment of peripheral artery disease, fostering the adoption of atherectomy devices. Minimally invasive procedures offer several advantages over traditional open surgeries, including reduced risk of complications, shorter hospital stays, and faster recovery times. Atherectomy procedures, characterized by small incisions and catheter-based techniques, enable targeted removal of atherosclerotic plaque while preserving vessel integrity and function. As patients and physicians increasingly prioritize minimally invasive approaches, the demand for atherectomy devices is expected to rise, driving market growth.
Increasing Emphasis on Outpatient Care
Segmental Insights
Product Insights
Based on the product, directional atherectomy devices have emerged as a dominant force, commanding a significant share of the market. Directional atherectomy devices employ a specialized cutting mechanism to precisely remove plaque from occluded arteries while minimizing damage to healthy vascular tissue. These devices typically feature a rotating cutting blade or burr positioned at the distal end of a catheter. As the catheter advances through the affected artery, the cutting blade engages with the plaque, allowing controlled removal through directional cutting motions.
One of the key factors driving the dominance of directional atherectomy devices is their proven efficacy in plaque removal across a wide range of lesion types and vessel anatomies. The directional cutting mechanism enables clinicians to navigate tortuous vessels and address complex lesions with greater precision and confidence. This versatility makes directional atherectomy devices suitable for a diverse patient population, including those with calcified or fibrous plaque, which may be challenging to treat with alternative methods. Directional atherectomy devices offer clinicians real-time feedback and control during the procedure, allowing for adjustments in cutting depth and direction as needed. This dynamic adaptability enhances procedural outcomes and contributes to high rates of procedural success and patient satisfaction.
End User Insights
Based on the end user segment, hospitals & surgical centers emerge as the dominant setting for atherectomy procedures, wielding considerable influence in shaping market dynamics and patient care pathways. Hospitals & surgical centers serve as the cornerstone of cardiovascular care, offering a comprehensive range of diagnostic, therapeutic, and surgical interventions for patients with atherosclerotic cardiovascular disease. These facilities boast state-of-the-art infrastructure, advanced imaging technologies, and a multidisciplinary team of healthcare professionals, including interventional cardiologists, vascular surgeons, and catheterization laboratory staff.
One of the key factors contributing to the dominance of hospitals & surgical centers in the atherectomy devices market is their capacity to handle complex and high-risk cases. Patients with severe arterial blockages, complex lesion morphologies, and comorbid conditions often require specialized care and advanced interventional techniques, such as atherectomy, to achieve optimal outcomes. Hospitals & surgical centers are well-equipped to address these challenging cases, offering specialized expertise, advanced procedural capabilities, and access to a comprehensive range of adjunctive therapies.
Regional Insights
North America stands out as the dominant region, commanding a significant share of market revenue and driving innovation, adoption, and utilization of atherectomy devices. This dominance is attributed to several key factors that underscore the region's robust healthcare infrastructure, technological advancements, and favorable reimbursement landscape. North America boasts a well-established healthcare ecosystem characterized by a network of leading hospitals, academic medical centers, and specialty clinics equipped with state-of-the-art facilities and advanced interventional cardiology laboratories. These institutions leverage atherectomy devices to address a wide spectrum of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and other vascular conditions, thereby driving substantial demand for atherectomy procedures and devices.
Recent Developments
- In January 2024, AngioDynamics, Inc., a prominent medical technology company dedicated to enhancing vascular health, expanding cancer therapies, and advancing patient well-being, announced today that the U.S. Food and Drug Administration (FDA) has approved the Auryon XL Catheter. This 225-cm radial access catheter is cleared for use alongside the Auryon Atherectomy System in treating Peripheral Arterial Disease (PAD).
- In February 2023, Abbott and Cardiovascular Systems, Inc. (CSI) entered into a definitive agreement, where Abbott will acquire CSI, a medical device company known for its innovative atherectomy system used in treating peripheral and coronary artery disease. Under the terms of the agreement, CSI shareholders will receive USD 20 per common share, resulting in an expected equity value totaling approximately USD 890 million. CSI specializes in atherectomy devices, which are minimally invasive tools used to remove plaque buildup from arteries, thereby improving blood flow. Atherectomy procedures complement traditional balloon angioplasty and stent placements, particularly in complex cases of arterial disease, enhancing treatment outcomes. Additionally, CSI has a pipeline of early-stage vascular intervention devices currently under development, aiming to further expand its portfolio of therapeutic solutions.
- In October 2023, Amplitude Vascular Systems (AVS) is developing an innovative approach to treating severe calcified arterial disease. The company's peripheral intravascular lithotripsy (IVL) system, named Pulse, is at the forefront of this initiative. Based in Boston, the startup aims to initiate patient enrollment in an investigational device exemption (IDE) study as early as next year.
- In October 2023, CardioFlow, Inc., a privately owned medical device firm specializing in minimallyinvasive solutions for peripheral artery disease (PAD), has announced therecent acquisition of U.S. Food and Drug Administration (FDA) 510(k) clearancefor its groundbreaking FreedomFlow Orbital Atherectomy Peripheral Platform. Thisinnovative platform is meticulously engineered to combat plaque blockageswithin the leg arteries, offering a modern mechanism of action. The proprietarydesign, delivered via catheter, harnesses the principles of angular momentum.This results in a unique spiral geometry, facilitating simultaneous contactbetween five diamond-coated spheres and the vessel wall, regardless of thedirection of advancement or retraction. A diamond-coated tip is incorporated tofacilitate the smooth passage of the driveshaft through narrow blockages,enhancing overall efficacy and patient outcomes.
Key Market Players
- Braun Melsungen AG
- Abbott Laboratories, Inc.
- Koninklijke Philips N.V.
- Boston Scientific Corporation
- Medtronic plc
- Becton, Dickinson, and Company
- Terumo Corporation
- Cardinal Health Inc.
- AngioDynamics Inc.
- Avinger Inc.
| By Product | By Application | By End User | By Region |
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy